Schroder Investment Management Group’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-15,000
Closed -$223K 1253
2024
Q4
$223K Hold
15,000
﹤0.01% 1167
2024
Q3
$301K Hold
15,000
﹤0.01% 1150
2024
Q2
$310K Sell
15,000
-771
-5% -$16.7K ﹤0.01% 1144
2024
Q1
$391K Buy
15,771
+318
+2% +$9.46K ﹤0.01% 1127
2023
Q4
$562K Buy
15,453
+11,221
+265% +$432K ﹤0.01% 1075
2023
Q3
$201K Buy
4,232
+234
+6% +$13.9K ﹤0.01% 1170
2023
Q2
$280K Buy
+3,998
New +$258K ﹤0.01% 1169

Other funds holding PRTA

Schroder Investment Management Group's PRTA Position: Q1 2025 in Review

Schroder Investment Management Group sold out of Prothena Corp (PRTA) in Q1 2025, closing a stake of 15,000 shares — an estimated $223K sold.

Schroder Investment Management Group first reported a position in PRTA in Q2 2023 and held it in 7 quarters. The position peaked at $562K in Q4 2023. 161 funds tracked by Wall St. Rank hold PRTA as of Q1 2025.

  • Schroder Investment Management Group reported no remaining Prothena Corp position as of Q1 2025 after selling out during the quarter.
  • Schroder Investment Management Group sold 15,000 Prothena Corp shares in Q1 2025, an estimated $223K.
  • Schroder Investment Management Group first reported a position in Prothena Corp in Q2 2023 and held it in 7 quarters.
  • Schroder Investment Management Group's Prothena Corp position peaked at $562K in Q4 2023.
  • 161 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2025.

Based on Schroder Investment Management Group's 13F filing for Q1 2025, filed 13 May 2025.